Mirae Asset Global Investments Co., Ltd. Alkermes Plc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Alkermes Plc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,392 shares of ALKS stock, worth $186,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,392
Previous 5,956
9.47%
Holding current value
$186,563
Previous $166,000
6.63%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$640 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$424 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$305 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$262 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.68B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...